(Q38118585)

29 August 2017

Chronic low back pain: pharmacological, interventional and surgical strategies (English)

1 reference

29 August 2017

0 references

1 reference

1

Bart Morlion

1 reference

PubMed ID

23817349

29 August 2017

language of work or name

English

0 references

publication date

2 July 2013

1 reference

29 August 2017

Nature Reviews Neurology

1 reference

29 August 2017

9

1 reference

29 August 2017

8

1 reference

29 August 2017

462-473

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2013.130

29 August 2017

0 references

cites work

Chapter 4. European guidelines for the management of chronic nonspecific low back pain.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

The rising prevalence of chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Cause or effect? Deconditioning and chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Prevalence and characteristics of widespread pain in female primary health care patients with chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

The influence of socio-demographic characteristics on consultation for back pain--a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Chapter 3. European guidelines for the management of acute nonspecific low back pain in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Outcome of low back pain in general practice: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Epidemiological features of chronic low-back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Clinical course of non-specific low back pain: a systematic review of prospective cohort studies set in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Neuropathic pain: redefinition and a grading system for clinical and research purposes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

The evaluation of neuropathic components in low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Synthesis of recommendations for the assessment and management of low back pain from recent clinical practice guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Early identification and management of psychological risk factors ("yellow flags") in patients with low back pain: a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Will this patient develop persistent disabling low back pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Imaging strategies for low-back pain: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

The biopsychosocial approach to chronic pain: Scientific advances and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Biopsychosocial analysis of low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

A supermarket approach to the evidence-informed management of chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Fibromyalgia diagnosis and diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Risk factors predicting the development of widespread pain from chronic back or neck pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Effect sizes of non-surgical treatments of non-specific low-back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

A long way to go: practice patterns and evidence in chronic low back pain care

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Psychological interventions in the rehabilitation of patients with chronic low back pain: evidence and recommendations from systematic reviews and guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Treatment of chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Exercise therapy for low back pain: a systematic review within the framework of the cochrane collaboration back review group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Clinical guidelines for the management of low back pain in primary care: an international comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

A systematic review of paracetamol for non-specific low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

PACE--the first placebo controlled trial of paracetamol for acute low back pain: design of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Non-steroidal anti-inflammatory drugs: What is the actual risk of liver damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Cardiovascular adverse effects of anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Antiplatelet drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Opioids for chronic pain: new evidence, new strategies, safe prescribing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Opioid dose and drug-related mortality in patients with nonmalignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

A randomized, placebo-controlled study of the impact of the 7-day buprenorphine transdermal system on health-related quality of life in opioid-naïve patients with moderate-to-severe chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Long-term safety and tolerability of tapentadol extended release for the management of chronic low back pain or osteoarthritis pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Nonsurgical interventional therapies for low back pain: a review of the evidence for an American Pain Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

The evidence for pharmacological treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

The costs and benefits of nonoperative management for adult scoliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Escitalopram 20 mg versus duloxetine 60 mg for the treatment of chronic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Practice guidelines for chronic pain management: an updated report by the American Society of Anesthesiologists Task Force on Chronic Pain Management and the American Society of Regional Anesthesia and Pain Medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Outcome of invasive treatment modalities on back pain and sciatica: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Guideline warfare over interventional therapies for low back pain: can we raise the level of discourse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Injection therapy and denervation procedures for chronic low back pain: a systematic review--clinical value?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

2009 ISSLS Prize Winner: Does discography cause accelerated progression of degeneration changes in the lumbar disc: a ten-year matched cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

21 January 2018

Lumbar facet syndromes

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Establishing an optimal "cutoff" threshold for diagnostic lumbar facet blocks: a prospective correlational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Assessment: use of epidural steroid injections to treat radicular lumbosacral pain: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

United States' trends and regional variations in lumbar spine surgery: 1992-2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Surgical interventions for lumbar disc prolapse: updated Cochrane Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Surgery for degenerative lumbar spondylosis: updated Cochrane Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Traumatic brain injury: CT scan does not predict outcome of mild traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

No difference in 9-year outcome in CLBP patients randomized to lumbar fusion versus cognitive intervention and exercises

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Lumbar spine fusion for chronic low back pain due to degenerative disc disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Spinal fusion for chronic low back pain: systematic review on the accuracy of tests for patient selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

The role of TNF-alpha in patients with chronic low back pain-a prospective comparative longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Nerve growth factor of cultured medium extracted from human degenerative nucleus pulposus promotes sensory nerve growth and induces substance p in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Epidural administration of spinal nerves with the tumor necrosis factor-alpha inhibitor, etanercept, compared with dexamethasone for treatment of sciatica in patients with lumbar spinal stenosis: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Modelling the prevalence and cost of back pain with neuropathic components in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Addressing occupational factors in the management of low back pain: implications for physical therapist practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

11. Lumbosacral radicular pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

12. Pain originating from the lumbar facet joints

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

13. Sacroiliac joint pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

15. Discogenic low back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

What is this thing called pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Facet joint pain--advances in patient selection and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Epidural steroids: a comprehensive, evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

The prevalence of low back pain: a systematic review of the literature from 1966 to 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

[Chronic back pain in the general population in Germany 2002/2003: prevalence and highly affected population groups]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Non-specific low back pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

The frequency of transition of chronic low back pain to fibromyalgia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Early management of persistent non-specific low back pain: summary of NICE guidance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Misinterpretation of evidence synthesis and ASIPP guidelines by Chou

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Behavioural treatment for chronic low-back pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Drug-induced liver injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Pharmacological management of persistent pain in older persons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Efficacy and safety of buprenorphine transdermal system (BTDS) for chronic moderate to severe low back pain: a randomized, double-blind study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Efficacy and safety of duloxetine in patients with chronic low back pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Evidence-based guidelines for interventional pain medicine according to clinical diagnoses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Failed back surgery syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Paradigm changes in spine surgery: evolution of minimally invasive techniques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Efficacy and safety of tanezumab in the treatment of chronic low back pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Treatment strategy for chronic low back pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2013.130

Guidelines warfare over interventional techniques: is there a lack of discourse or straw man?

31 March 2020

1 reference

12 December 2020

Failed back surgery syndrome: 5-year follow-up in 102 patients undergoing repeated operation

1 reference

12 December 2020

Prevalence and predictors of intense, chronic, and disabling neck and back pain in the UK general population

1 reference

12 December 2020

Tapentadol in the management of chronic low back pain: a novel approach to a complex condition?

1 reference

12 December 2020

Prescribing NSAIDs to patients on SSRIs: possible adverse drug interaction of importance to dental practitioners.

1 reference

12 December 2020

Growth of spinal interventional pain management techniques: analysis of utilization trends and Medicare expenditures 2000 to 2008.

1 reference

12 December 2020

A critical review of the American Pain Society clinical practice guidelines for interventional techniques: part 1. Diagnostic interventions.

1 reference

12 December 2020

Effectiveness of therapeutic lumbar transforaminal epidural steroid injections in managing lumbar spinal pain.

1 reference

12 December 2020

Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation

1 reference

12 December 2020

Efficacy of tapentadol ER for managing moderate to severe chronic pain

1 reference

12 December 2020

A critical look at the treatment for low back pain

1 reference

12 December 2020

A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's Guide

1 reference

12 December 2020

A critical review of the American Pain Society clinical practice guidelines for interventional techniques: part 2. Therapeutic interventions.

1 reference

12 December 2020

10.1038/NRNEUROL.2013.130

Identifiers

DOI

1 reference

PubMed ID

23817349

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

23817349